ID   NM-F9
AC   CVCL_IQ45
SY   K562-F9
DR   Wikidata; Q54930804
RX   Patent=US8283161;
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2606.
CC   Sequence variation: BCR-ABL1 gene fusion (from parent cell line).
CC   Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line).
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from sampling site: Pleural effusion.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 05-07-19; Version: 7
//
RX   Patent=US8283161;
RA   Goletz S., Baumeister H., Schlangstedt M., Schober U.;
RT   "Tumour cell lines and uses thereof.";
RL   Patent number US8283161, 09-Oct-2012.
//